Archives
-
Danazol Workflows for Endocrine Research
2026-09-29
Danazol enables controlled interrogation of steroidogenesis, LH regulation, and androgen-sensitive biology across cell and animal models. This practical guide translates a recent precocious-puberty study into reproducible formulation, assay, troubleshooting, and translational workflows while distinguishing research use from clinical use of Danocrine.
-
CGRP/SP–Piezo2 Signaling in Trigeminal Neuralgia
2026-09-29
Liao et al. identify a Ca2+-dependent CGRP/SP–Piezo2 positive-feedback loop linking trigeminal root compression, neuroinflammation, and mechanical allodynia. Their rat and in vitro experiments connect ATP, PKC, cAMP signaling, MAPK activation, Merkel-cell mechanotransduction, and behavioral hypersensitivity, providing a mechanistic framework for studying trigeminal neuralgia.
-
Molidustat Workflows for HIF and Renal Anemia
2026-09-28
Molidustat (BAY85-3934) provides a controllable way to stabilize HIF and examine erythropoietin signaling, hypoxia adaptation, and chronic kidney disease anemia. This practical guide connects dose design with Septin4–VHL–HIF-1α assays, highlighting controls, comparative advantages, and troubleshooting strategies.
-
How PLGA Nanoparticle Design Shapes Corneal Uptake
2026-09-28
Azadi and David tested how particle size and surface chemistry affect uptake of PLGA nanoparticles by human corneal epithelial cells in a model that included simulated mucosal solution. Their findings identify size- and coating-dependent uptake patterns and implicate macropinocytosis and caveolae-mediated endocytosis as dominant routes under the tested conditions, informing—but not yet resolving—the design of topical ocular carriers.
-
TPA Workflows for ERK/MAPK Signaling Research
2026-09-27
Use 12-O-tetradecanoyl phorbol-13-acetate (TPA) as a direct PKC-pathway perturbation to benchmark ERK/MAPK responses, rather than as a receptor-specific stimulus. This guide pairs practical signaling workflows with a cautious framework for investigating how host-cell signaling relates to polymicrobial infection and neutrophil extracellular traps.
-
TPA in Immune Signaling: What It Can—and Cannot—Model
2026-09-26
12-O-tetradecanoyl phorbol-13-acetate (TPA) is a useful PKC-to-ERK stimulus, but it is not a stand-in for immune-receptor signaling. This article connects its experimental strengths and limits to recent allergic-rhinitis research on ICOS and T-cell differentiation.
-
Go 6983: Evidence and Workflow for PKC Research
2026-09-25
Go 6983 is a pan-PKC inhibitor used to investigate PKC-dependent signaling, with reported nanomolar potency against several PKC isoforms. This evidence-focused guide distinguishes the compound’s reported benchmarks from practical workflow recommendations and clarifies what the available data do not establish.
-
Dovitinib and the Next Layer of Cancer Biology
2026-09-25
Dovitinib (TKI-258) offers a way to interrogate receptor tyrosine kinase signaling, while recent prostate cancer research highlights a distinct layer of regulation involving circRNA and protein localization. This article separates established evidence from exploratory hypotheses and outlines a practical strategy for translational researchers.
-
Rottlerin as a Translational Probe Beyond PKCδ
2026-09-24
Rottlerin can help translational researchers connect PKC-dependent signaling with proliferation and apoptosis readouts—provided its reported selectivity is tested in the biological context. This article outlines a rigorous validation strategy and draws a careful methodological connection to nanoparticle uptake research without implying unproven ocular efficacy.
-
From mRNA Uptake to Function: A Translational Playbook
2026-09-24
Dual-readout reporter mRNA can help researchers separate cellular uptake from productive translation. This article connects that measurement strategy to emerging targeted-delivery research, including β-cell-directed lipid nanoparticles, and outlines practical ways to use Cy5 and EGFP signals without overinterpreting either.
-
3D Shell MEAs Map Cardiac Organoid Electrophysiology
2026-09-23
Shape-adaptive shell microelectrode arrays let researchers map electrical activity across cardiac organoids in three dimensions, addressing a key limitation of conventional planar MEAs. The study combines electrophysiological mapping with calcium imaging and pharmacological challenges, providing a framework for studying conduction dynamics and drug responses in organoid models.
-
Dasatinib: Mechanistic Assay Design in Cancer
2026-09-23
Dasatinib (BMS-354825) is a Src and Bcr-Abl inhibitor for dissecting kinase-dependent cancer phenotypes. This guide connects its established assay applications with the SNAI1–PIK3R2/p-EphA2 findings in thymic epithelial tumors to improve experimental interpretation without overstating translational evidence.
-
G-1: Selective GPR30 Agonist Workflows
2026-09-22
G-1 enables receptor-focused studies of rapid estrogen signaling without relying on classical ERα or ERβ activation. This workflow-centered guide covers calcium and PI3K assays, breast cancer migration experiments, cardiovascular models, formulation, and troubleshooting.
-
Intravesical p21 mRNA-LNP Therapy for Bladder Cancer
2026-09-22
This FASEB Journal study develops chemically modified p21 mRNA-loaded lipid nanoparticles for localized intravesical treatment of bladder cancer. The work links restoration of nuclear p21 to cell-cycle inhibition, DNA-damage signaling, apoptosis, and tumor suppression while showing bladder-localized expression with limited systemic distribution in an orthotopic mouse model.
-
Rapamycin and EV Biology: A Translational Strategy
2026-09-21
Rapamycin (Sirolimus) is best known as an mTOR-pathway inhibitor, but emerging B-cell extracellular-vesicle research creates a new translational question: can mTOR modulation alter the selective release of bioactive ectosomes? This article connects that hypothesis to experimental design, pathway controls, competitive positioning, and realistic opportunities in cancer, immunology, and mitochondrial disease research.